(Q44245840)

English

A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women

scientific article published in December 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

Barbara Guzic Salobir

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Irena Keber

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lucija Vrabic

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

78

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1178-1183

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Risk of venous thromboembolism in users of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Coagulation activation following estrogen administration to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

EFFECTS OF ESTROGEN REPLACEMENT THERAPY ON THROMBIN GENERATION

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Haemostatic changes during continuous oestradiol-progestogen treatment of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Compliance with long-term oral hormonal replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Effect of tamoxifen on measurements of hemostasis in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Fibrin D-dimer: a useful clinical marker of thrombogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904291-7

7 January 2021

Identifiers

10.1016/S0015-0282(02)04291-7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44245840&oldid=2108885044"